Quantitation of proliferative and cytotoxic precursor cells directed against human tumours: limiting dilution analysis in peripheral blood and at the tumour site.
dc.contributor.author | Vose, Brent M | |
dc.date.accessioned | 2011-05-13T14:55:34Z | |
dc.date.available | 2011-05-13T14:55:34Z | |
dc.date.issued | 1982-08-15 | |
dc.identifier.citation | Quantitation of proliferative and cytotoxic precursor cells directed against human tumours: limiting dilution analysis in peripheral blood and at the tumour site. 1982, 30 (2):135-42 Int J Cancer | en |
dc.identifier.issn | 0020-7136 | |
dc.identifier.pmid | 6215363 | |
dc.identifier.doi | 10.1002/ijc.2910300202 | |
dc.identifier.uri | http://hdl.handle.net/10541/129531 | |
dc.description.abstract | Blood and tumour-infiltrating lymphocytes (TIL) from 16 cancer patients have been examined under limiting dilution conditions to determine the frequency of cells responding in mixed tumour-lymphocyte cultures (MLTC) to autologous tumour and Interleukin-2 (IL-2). Tumour-derived lymphocytes showed a high spontaneous response to IL-2 alone 1/1,900 in TIL; 1/6,000 in PBL suggesting the presence of "activated" T cells in situ. Proliferative frequencies were increased in MLTC in both blood (1/3,779) and TIL (1/1,084). Phenotypic analyses showed that total T-cell contents of the responder populations were comparable but TIL were enriched for the OKT8+ subset with a corresponding reduction in OKT4+. TIL showed increased numbers of OKMI+ and Tac+ lymphocytes. The major cytotoxic precursor expanding under these conditions was reactive against autologous tumour. K562 (NK) were present at a lesser frequency--particularly in TIL. The data show a concentration and activation of reactive lymphocytes at the tumour site and establish conditions for the clonal expansion of specifically cytotoxic T cells. | |
dc.language.iso | en | en |
dc.subject.mesh | Cell Division | |
dc.subject.mesh | Cytotoxicity, Immunologic | |
dc.subject.mesh | Humans | |
dc.subject.mesh | Interleukin-2 | |
dc.subject.mesh | Lymphocyte Activation | |
dc.subject.mesh | Lymphocyte Culture Test, Mixed | |
dc.subject.mesh | Lymphocytes | |
dc.subject.mesh | Neoplasms | |
dc.title | Quantitation of proliferative and cytotoxic precursor cells directed against human tumours: limiting dilution analysis in peripheral blood and at the tumour site. | en |
dc.type | Article | en |
dc.contributor.department | Paterson Laboratories, Christie Hospital and Holt Radium Institute, Withington, Manchester, M20 9BX, UK | en |
dc.identifier.journal | International Journal of Cancer | en |
html.description.abstract | Blood and tumour-infiltrating lymphocytes (TIL) from 16 cancer patients have been examined under limiting dilution conditions to determine the frequency of cells responding in mixed tumour-lymphocyte cultures (MLTC) to autologous tumour and Interleukin-2 (IL-2). Tumour-derived lymphocytes showed a high spontaneous response to IL-2 alone 1/1,900 in TIL; 1/6,000 in PBL suggesting the presence of "activated" T cells in situ. Proliferative frequencies were increased in MLTC in both blood (1/3,779) and TIL (1/1,084). Phenotypic analyses showed that total T-cell contents of the responder populations were comparable but TIL were enriched for the OKT8+ subset with a corresponding reduction in OKT4+. TIL showed increased numbers of OKMI+ and Tac+ lymphocytes. The major cytotoxic precursor expanding under these conditions was reactive against autologous tumour. K562 (NK) were present at a lesser frequency--particularly in TIL. The data show a concentration and activation of reactive lymphocytes at the tumour site and establish conditions for the clonal expansion of specifically cytotoxic T cells. |